Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
about
Pathophysiology of thrombotic thrombocytopenic purpuraVon Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpuraCurrent concepts in thrombotic thrombocytopenic purpuraProteolytic processing of von Willebrand factor by adamts13 and leukocyte proteasesRituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.Enzymatically active ADAMTS13 variants are not inhibited by anti-ADAMTS13 autoantibodies: a novel therapeutic strategy?ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura in the setting of adult-onset Still's diseaseBench-to-bedside review: thrombocytopenia-associated multiple organ failure--a newly appreciated syndrome in the critically illThrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiencyEvolution of ADAMTS13 antibodies in a fatal case of thrombotic thrombocytopenic purpura.Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failureMechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura.An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura.Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models.Efficacy and Safety Profile of Solvent/Detergent Plasma in the Treatment of Acute Thrombotic Thrombocytopenic Purpura: A Single-Center ExperienceWhy Do We Need ADAMTS13?Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura
P2860
Q24614117-DCEF0CA6-D817-4538-B77E-B485F044F88AQ24651320-86B67B47-3D56-428B-BCB7-9DBD7BF9617FQ24656680-ACBA0401-7FD6-42EB-8E8E-98EC98B0332AQ26827966-6D0C6F14-2CFB-4CE7-8983-59A967F70023Q33359900-84EF9EF1-1696-4E3A-9BC3-C756973FC373Q33368779-31CBA9E9-872B-47DF-90D6-7B3CA3855623Q33371103-4D857752-7928-4F64-98B2-CD7AC15775F0Q33371300-E13742E4-72CE-423D-8875-0EABCA899A81Q33373238-EDC5D665-247E-4D2E-85BD-2FA8C98E5885Q33376071-E11BF950-27F7-418D-BB7B-D3965CF2FEF3Q33380521-8B663B30-81EC-44D3-ACE8-14B5A00AB636Q33381364-2A26766D-E8FF-45C4-BA82-9A29DCA5B4E3Q33382999-D975A35B-A6BE-4D17-BEA2-8982F2C9466EQ33408427-5367D655-EAA1-4B49-84FC-29CD8A8EC7F2Q33421373-171CB80F-C92E-4EF5-AD7F-ED3F3643E82FQ34038164-A1E27BE7-1A28-4FC5-80E7-781F6120EBCFQ35062975-C104A8B9-3AC9-429C-A434-C24BFE196C8EQ42434776-E1A35BD3-2B77-4610-87F9-E0701528EAF5
P2860
Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inhibitors of von Willebrand f ...... otic thrombocytopenic purpura.
@ast
Inhibitors of von Willebrand f ...... otic thrombocytopenic purpura.
@en
Inhibitors of von Willebrand f ...... otic thrombocytopenic purpura.
@nl
type
label
Inhibitors of von Willebrand f ...... otic thrombocytopenic purpura.
@ast
Inhibitors of von Willebrand f ...... otic thrombocytopenic purpura.
@en
Inhibitors of von Willebrand f ...... otic thrombocytopenic purpura.
@nl
prefLabel
Inhibitors of von Willebrand f ...... otic thrombocytopenic purpura.
@ast
Inhibitors of von Willebrand f ...... otic thrombocytopenic purpura.
@en
Inhibitors of von Willebrand f ...... otic thrombocytopenic purpura.
@nl
P2093
P1433
P1476
Inhibitors of von Willebrand f ...... botic thrombocytopenic purpura
@en
P2093
P304
P577
2001-01-01T00:00:00Z